Prudential Financial Inc Relay Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $80 Billion
- Q3 2025
A detailed history of Prudential Financial Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 14,825 shares of RLAY stock, worth $93,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,825
Previous 358,225
95.86%
Holding current value
$93,249
Previous $1.24 Million
93.79%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RLAY
# of Institutions
209Shares Held
163MCall Options Held
694KPut Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$176 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$84.6 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$84 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.3MShares$71.3 Million8.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$66.3 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $756M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...